Unknown

Dataset Information

0

Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease.


ABSTRACT: Diabetes is the major risk factor for end-stage renal disease (ESRD) worldwide. In advanced chronic kidney disease (CKD), less is known about the predictive value of HbA1c. We enrolled 2401 diabetic patients with stage 3-4 and stage 5 CKD, who were classified into 4 groups according to their baseline HbA1c values (<6%, 6%-7%, 7%-9%, and >9%). During the median follow-up of 3 years, 895 patients developed ESRD, and 530 died. In linear regression analysis, higher HbA1c correlated with higher eGFR in patients with stage 5 CKD but not in stage 3-4 CKD. In Cox regression analysis, a trend toward worse clinical outcomes existed when the HbA1c level exceeded 6% in stage 3-4 CKD, but the significance was only observed for >9%. The hazard ratios (HRs) for ESRD, all-cause mortality and combined CV events with mortality in the group of HbA1c >9% were 1.6 (95% CI, 1.07 to 2.38), 1.52 (95% CI, 0.97 to 2.38) and 1.46 (95% CI, 1.02 to 2.09), respectively. This study demonstrates that the higher HbA1c level is associated higher risks for clinical outcomes in diabetic patients with stage 3-4 CKD but not in stage 5 CKD.

SUBMITTER: Kuo IC 

PROVIDER: S-EPMC4730215 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC6014665 | biostudies-literature
| S-EPMC4845823 | biostudies-other
| S-EPMC10447421 | biostudies-literature
| S-EPMC6411440 | biostudies-literature
| S-EPMC3820602 | biostudies-literature
| S-EPMC5180243 | biostudies-literature
| S-EPMC7085830 | biostudies-literature
| S-EPMC8637116 | biostudies-literature
| S-EPMC10432358 | biostudies-literature
| S-EPMC4597990 | biostudies-literature